US FDA panel backs Innoviva's drug for multidrug-resistant bacterial infections

Innoviva

17/04/2023 21:37

April 17 (Reuters) - A panel of U.S. Food and Drug
Administration advisers on Monday unanimously voted in favor of
Innoviva Inc's  INVA.O   experimental antibiotic in the
treatment of serious bacterial infections, typically associated
with hospitalizations, the company said.

 (Reporting by Sriparna Roy and Raghav Mahobe in Bengaluru;
Editing by Krishna Chandra Eluri)
 ((Sriparna.Roy@thomsonreuters.com;))